Market Research Logo

Pre-Filled Syringes Europe

SMi proudly announces the return of the 9th Annual Pre-Filled Syringes to London in Jan 2017!

The global market for pre-filled syringes will grow substantially over the next five years to reach sales of $6.6 billion, according to a new report from Smithers Rapra, a worldwide authority on the plastics and rubber industry supply chains. The report estimates that there are approximately 3.5 billion pre-filled syringe units produced a year and this will grow to 6.7 billion units by 2020.

The market has witnessed continual advancements in device design with enhanced safety and usability by patients through human factor engineering. Nonetheless, challenges surrounding biologic drug stability, manufacturing and competition from other drug delivery technologies remain key concerns amongst pharma and medical device manufacturers.

Emulating on SMi’s successful PFS series, this must-attend event returns to London. Join us today to discuss with your industry colleagues to accelerate PFS development and innovation!


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Alphons Fakler, Group Head Risk Management, Novartis Pharma
9:10
Regulatory aspects of pre-filled syringes - Latest regulatory updates from MHRA
Vikas Jaitely , Deputy Manager and Senior Pharmaceutical Assessor Licensing Division, Medicines and Healthcare Products Regulatory Agency (MHRA)
9:50
New technologies for pre-filled syringes – streamlining innovation
Alexander Jung, Senior Manager Technology and Innovation, Drug Delivery & Devices, Boehringer Ingelheim
9:50
New technologies for pre-filled syringes – streamlining innovation
Christian Dechant, Primary Packaging Director, Boehringer Ingelheim
10:30
Components and systems selection strategies for pre-filled syringes, risk mitigation, performance and quality
Christa Jansen-Otten, Director Global Product Management Prefilled Systems and Delivery, West Pharmaceutical Services
11:10
Morning Coffee & Networking Break
11:40
Device design implications of increasing dose volume on injection time and patient factors
David Blakely, Device Development Manager, GSK
12:20
Combination products: a need for flexible and customisable drug delivery devices
Adrien Tisserand, Category Manager - Parenteral, Nemera
13:00
Networking Lunch
14:10
Engineering of delivery system integration for biologics and primary containers
Paolo Mangiagalli, Senior Director - PFS Platform, Sanofi
14:50
Introduction of an innovative and groundbreaking in-line X-ray inspection technology in a pre-fillable syringe manufacturing line
Matteo Falgari, Sales Manager PFS, Nipro PharmaPackaging
15:30
Afternoon Tea & Networking Break
16:00
Ocular injection - PFS development
Markus Hemminger, Senior Engineer Pre-Filled Syringes, F. Hoffmann-La Roche
16:40
Panel Discussion: Combination products – challenges and opportunities
Alphons Fakler, Group Head Risk Management, Novartis Pharma
16:40
Panel Discussion: Combination products – challenges and opportunities
Serkan Oray, Senior Director, Device & Technology, UCB
16:40
Panel Discussion: Combination products – challenges and opportunities
David Ottolangui, Device Technology Director, GSK
16:40
Panel Discussion: Combination products – challenges and opportunities
Ed Cahill, Senior Director, Technical and Scientific Affairs, Teva
17:00
Chairman’s Closing Remarks and Close of Day One
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Alphons Fakler, Group Head Risk Management, Novartis Pharma
9:10
Regulatory updates – recent guidelines on Human Factors Engineering
Nick Stones, Fellow, Human Factors Engineer, Novartis
9:50
Formulation and drug delivery challenges for mid-sized companies
Sachin Dubey, Head of Formulation , Glenmark Pharmaceuticals
10:30
An insight into the preferences for injection devices in rheumatoid arthritis patients
Richard Featherstone, Managing Director, Medical Device Usability
11:10
Morning Coffee & Networking Break
11:40
An update on Polymer-based pre-fillable syringes addressing the challenges of therapeutic proteins
William Dierick, Director Technology Development, Terumo Pharmaceutical Solutions
12:20
Siliconisation - influence on functionality
Vincent Cazanave, Pre-Fillable Syringe Engineering Device Development, Roche
13:00
Networking Lunch
14:10
OXYCAPT multilayer plastic syringes having excellent oxygen and water vapor barrier
Kenichiro Usuda, Researcher, Advanced Business Development Division, Mitsubishi Gas Chemical Company
14:50
From filling to packaging
Andreas Kerschbaumer, Facilitator Compouding, Filling & Inspection, Sandoz
15:30
Afternoon Tea & Networking Break
16:00
Stability of Pharmaceutical Proteines in contact with Cyclo Olefin Polymer (COP) Syringes
Reinhard Scheller, Commercial Manager Cyclo Olefin Polymers - COP, Zeon Europe GmbH
16:40
Panel Discussion: The future of parenteral drug delivery - moving from drug delivery devices to therapy management ecosystems
Alphons Fakler, Group Head Risk Management, Novartis Pharma
16:40
Panel Discussion: The future of parenteral drug delivery - moving from drug delivery devices to therapy management ecosystems
Ignace Wallaert, Principal Scientist Packaging Development, Janssen Pharmaceutica
17:20
Chairman's Closing Remarks and Close Day Two

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report